Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Self-Evaluation: Self-Enhancement and Self-Verification03:00

Self-Evaluation: Self-Enhancement and Self-Verification

5.8K
Social psychologists have documented that feeling good about ourselves and maintaining positive self-esteem is a powerful motivator of human behavior (Tavris & Aronson, 2008). In the United States, members of the predominant culture typically think very highly of themselves and view themselves as good people who are above average on many desirable traits (Ehrlinger, Gilovich, & Ross, 2005). Often, our behavior, attitudes, and beliefs are affected when we experience a threat to our...
5.8K
Muscle Recovery and Fatigue01:24

Muscle Recovery and Fatigue

4.2K
Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective...
4.2K
Bioavailability Enhancement: Drug Solubility Enhancement01:16

Bioavailability Enhancement: Drug Solubility Enhancement

261
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
261
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

205
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
205
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

958
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
958
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.5K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Navigating Multimodality Therapy in Non-Small Cell Lung Cancer: Neoadjuvant-Only Versus Perioperative Immunotherapy, Surgical Imperatives, and Future Approaches.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting·2026
Same author

Improving neoadjuvant and perioperative therapy in non-small-cell lung cancer.

Nature reviews. Clinical oncology·2026
Same author

The environmental impacts of surgical care pathways: same-day-discharge versus enhanced recovery following minimally invasive colectomy and stoma reversal.

Surgical endoscopy·2026
Same author

Impact of the Quebec Provincial Enhanced Recovery After Surgery Program on Postoperative Outcomes for Patients Undergoing Colorectal Operation.

Journal of the American College of Surgeons·2026
Same author

SAGES colorectal and metabolic bariatric surgery committee joint task force call to action for synchronized severe obesity and colorectal cancer management.

Surgical endoscopy·2026
Same author

Long-Term Safety and Efficacy of Pegvaliase in Japanese Adults With Phenylketonuria: Final Results of a Phase III Trial.

JIMD reports·2026

Related Experiment Video

Updated: Feb 1, 2026

Enhanced Oil Recovery using a Combination of Biosurfactants
13:19

Enhanced Oil Recovery using a Combination of Biosurfactants

Published on: June 3, 2022

6.0K

Enhanced recovery after pulmonary surgery.

Jules Eustache1, Lorenzo E Ferri2, Liane S Feldman3

  • 1Department of General Surgery, McGill University Health Centre, Montreal, Canada.

Journal of Thoracic Disease
|December 4, 2018
PubMed
Summary

Enhanced recovery pathways (ERPs) are crucial for surgical recovery, but standardization in pre- and post-operative phases, especially in pulmonary surgery, needs more research. Novel components and better recovery metrics are essential for optimizing patient outcomes.

Keywords:
Enhanced recovery pathway (ERP)enhanced recoveryfast-trackpathwaypulmonary

More Related Videos

Surgery and Sample Processing for Correlative Imaging of the Murine Pulmonary Valve
07:34

Surgery and Sample Processing for Correlative Imaging of the Murine Pulmonary Valve

Published on: August 5, 2021

3.0K
Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension
09:23

Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension

Published on: February 11, 2017

17.4K

Related Experiment Videos

Last Updated: Feb 1, 2026

Enhanced Oil Recovery using a Combination of Biosurfactants
13:19

Enhanced Oil Recovery using a Combination of Biosurfactants

Published on: June 3, 2022

6.0K
Surgery and Sample Processing for Correlative Imaging of the Murine Pulmonary Valve
07:34

Surgery and Sample Processing for Correlative Imaging of the Murine Pulmonary Valve

Published on: August 5, 2021

3.0K
Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension
09:23

Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension

Published on: February 11, 2017

17.4K

Area of Science:

  • Surgical recovery and patient management.
  • Enhanced recovery pathways (ERPs) in thoracic surgery.

Background:

  • Surgical recovery spans pre-, peri-, and post-operative phases.
  • Enhanced recovery pathways (ERPs) aim to optimize the entire patient trajectory.
  • Standardization of pre- and post-operative phases within ERPs remains debated, particularly in pulmonary surgery.

Purpose of the Study:

  • To review current developments in enhanced recovery pathways (ERPs) for pulmonary surgery.
  • To emphasize novel components for pre- and post-operative care in pulmonary surgery ERPs.
  • To discuss limitations in current recovery metrics and suggest future research directions.

Main Methods:

  • Literature review focusing on enhanced recovery pathways in pulmonary surgery.
  • Analysis of current components and metrics used in surgical recovery pathways.
  • Identification of novel pre- and post-operative care strategies.

Main Results:

  • Limited data and lack of consensus exist regarding ERP components for pulmonary surgery.
  • The strength of ERPs lies in the combination of multiple components, not individual elements.
  • Current metrics for assessing recovery are insufficient for robust pathway evaluation.

Conclusions:

  • Further research is needed to standardize pre- and post-operative care within pulmonary surgery ERPs.
  • Development of representative recovery metrics is crucial for optimizing patient outcomes.
  • Future studies should focus on novel components and integrated approaches to enhance recovery.